2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular …
S Halvorsen, J Mehilli, S Cassese, TS Hall… - European heart …, 2022 - academic.oup.com
Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …
evidence shows that it can be considered medically appropriate to a given condition and if …
Obesity in children and adolescents: epidemiology, causes, assessment, and management
H Jebeile, AS Kelly, G O'Malley… - The lancet Diabetes & …, 2022 - thelancet.com
This Review describes current knowledge on the epidemiology and causes of child and
adolescent obesity, considerations for assessment, and current management approaches …
adolescent obesity, considerations for assessment, and current management approaches …
A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic …
C Boutari, CS Mantzoros - Metabolism, 2022 - Elsevier
The WHO just released in May 2022 a report on the state of the obesity pandemic in Europe,
stating that 60% of citizens in the area of Europe are either overweight or obese, and …
stating that 60% of citizens in the area of Europe are either overweight or obese, and …
[HTML][HTML] Prevalence trends of site‐specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019
H Long, Q Liu, H Yin, K Wang, N Diao… - Arthritis & …, 2022 - Wiley Online Library
Objective To estimate systematic and anatomic site–specific age‐standardized prevalence
rates (ASRs) and analyze the secular trends of osteoarthritis (OA) at global, regional, and …
rates (ASRs) and analyze the secular trends of osteoarthritis (OA) at global, regional, and …
Heart disease and stroke statistics—2023 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
[HTML][HTML] The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases
VS Malik, FB Hu - Nature Reviews Endocrinology, 2022 - nature.com
Sugar-sweetened beverages (SSBs) are a major source of added sugars in the diet. A
robust body of evidence has linked habitual intake of SSBs with weight gain and a higher …
robust body of evidence has linked habitual intake of SSBs with weight gain and a higher …
2019 Global NAFLD prevalence: a systematic review and meta-analysis
Background & Aims The increasing rates of obesity and type 2 diabetes mellitus may lead to
increased prevalence of nonalcoholic fatty liver disease (NAFLD). We aimed to determine …
increased prevalence of nonalcoholic fatty liver disease (NAFLD). We aimed to determine …
[HTML][HTML] The genetics of obesity: from discovery to biology
The prevalence of obesity has tripled over the past four decades, imposing an enormous
burden on people's health. Polygenic (or common) obesity and rare, severe, early-onset …
burden on people's health. Polygenic (or common) obesity and rare, severe, early-onset …
[PDF][PDF] Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance
Non-nutritive sweeteners (NNS) are commonly integrated into human diet and presumed to
be inert; however, animal studies suggest that they may impact the microbiome and …
be inert; however, animal studies suggest that they may impact the microbiome and …
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …
FLJ Visseren, F Mach, YM Smulders… - European heart …, 2021 - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …